Tag: drug safety

Prescribers have varying concerns about substituting generic versions of Narrow Therapeutic Index (NTI) drugs due to risks of adverse effects. Key factors include regulatory guidelines, specialty-specific practices, and communication between pharmacists and doctors. Real-world data shows substitution impacts on patient monitoring and costs. Current trends point to evolving policies and increased reliance on clinical evidence.